Sertraline treatment of elderly patients with depression and cognitive impairment
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Background: There is little information on the efficacy and side effects of antidepressant treatment in elderly patients with combined depression and cognitive impairment without dementia (DEP‐MCI), and it is unclear if cognitive performance improves with antidepressant response in these patients. Methods: In 39 elderly DEP‐MCI patients, changes in depression and cognitive impairment were evaluated with open sertraline treatment up to 200 mg/day for 12 weeks. Results: Of the 26 completers, 17 were responders and nine were non‐responders. Diagnostic subtype of depression was unrelated to response. ANCOVA on WAIS‐R digit symbol percent change scores revealed a significant effect for responder status (F = 5.59, p < 0.03), and age (F = 0.24, p < 0.64) and education (F = 1.64, p < 0.22) were not significant covariates. From pre‐trial to post‐trial, responders improved in WAIS‐R digit symbol percent change scores (Mean −10% SD 24) while non‐responders declined (Mean 14% SD 18; t = 2.60, p < 0.02). Other neuropsychological measures were unrelated to response. Percent change in HRSD scores showed significant inverse correlations with percent change in several cognitive measures. Conclusions: DEP‐MCI patients showed moderate clinical response to sertraline treatment. When responders were compared to non‐responders, cognitive improvement was limited to one measure of attention and executive function. Overall, there was little cognitive improvement with antidepressant treatment. The findings indirectly suggest that lack of improvement in cognition following treatment of depression in DEP‐MCI patients may be associated with increased risk of meeting diagnostic criteria for dementia during follow‐up. Copyright © 2003 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Blessed, G., Tomlinson, B. E., & Roth, M. (1968) · British Journal of Psychiatry · doi:10.1192/bjp.114.512.797 · Cited by 4,117 · cited 1×
“The modified Blessed Functional Activity Scale (Parts I and II) was used to assess activities of daily life (Blessed et al., 1968; Stern et al., 1990).”
MethodDepression and memory impairment: A meta-analysis of the association, its pattern, and specificity.
Burt, D. B., Zembar, M. J., & Niederehe, G. (1995) · Psychological Bulletin · doi:10.1037/0033-2909.117.2.285 · Cited by 903 · cited 5×
“Clinical trials using tricyclic antidepressants (TCAs) or electroconvulsive therapy (ECT) in elderly patients with major depression (MDD) suggest that cognitive deficits often improve along with recovery from depression (Reynolds et al., 1987; Sackeim et al., 1993).”
BackgroundInfluentialBoone, K. B. (1992) · Archives of Neurology · doi:10.1001/archneur.1992.00530290141024 · Cited by 400 · cited 3×
“…memory, and global cognitive performance, indicating that improvement in depression (lower HRSD scores) was associated with improvement in neuropsychological test performance in these areas, as has been reported in studies of depressed patients (Boone et al., 1992; Kindermann and Brown, 1997).”
BackgroundResultInfluentialChen, P., Ganguli, M., Mulsant, B. H., & DeKosky, S. T. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.3.261 · Cited by 327
Nyth, A. L., Gottfries, C. G., Lyby, K., Smedegaard‐Andersen, L., Gylding‐Sabroe, J., Kristensen, M., Refsum, H. ‐., Öfsti, E., Eriksson, S., & Syversen, S. (1992) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1992.tb03242.x · Cited by 258
A Double-Blind Comparison of Sertraline and Fluoxetine in Depressed Elderly Outpatients
Newhouse, P. A., Krishnan, K. R. R., Doraiswamy, P. M., Richter, E. M., Batzar, E. D., & Clary, C. M. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0804 · Cited by 163 · cited 1×
“Therefore, the findings with measures of attention in these DEP-MCI patients are only partly consistent with prior studies involving successful treatment of depression (Kindermann and Brown, 1997; Newhouse et al., 2000).”
ResultMeasurement and prediction of functional capacity in Alzheimer's disease
Stern, Y., Hesdorffer, D., Sano, M., & Mayeux, R. (1990) · Neurology · doi:10.1212/wnl.40.1.8 · Cited by 147 · cited 1×
“The modified Blessed Functional Activity Scale (Parts I and II) was used to assess activities of daily life (Blessed et al., 1968; Stern et al., 1990).”
MethodSelf-citation
Cited by
Depression and risk of developing dementia
Byers, A. L., & Yaffe, K. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.60 · Cited by 1,265
SIM, S., RISINGER, C., DAHL, M., AKLILLU, E., CHRISTENSEN, M., BERTILSSON, L., & INGELMANSUNDBERG, M. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.10.002 · Cited by 732
Antidepressants for agitation and psychosis in dementia
Seitz, D. P., Adunuri, N., Gill, S. S., Gruneir, A., Herrmann, N., & Rochon, P. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008191.pub2 · Cited by 304
Reliability of the Hamilton Rating Scale for Depression: A meta-analysis over a period of 49years
Trajković, G., Starčević, V., Latas, M., Leštarević, M., Ille, T., Bukumirić, Z., & Marinković, J. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2010.12.007 · Cited by 303
“For example, Bech et al. (2002) found an alpha coefficient of 0.81 and Devanand et al. (2003) reported an intraclass correlation coefficient for inter-rater reliability of 0.95.”
InfluentialNaismith, S. L., Norrie, L. M., Mowszowski, L., & Hickie, I. B. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.05.009 · Cited by 270
Longitudinal Assessment of Neuropsychological Function in Major Depression
Douglas, K. M., & Porter, R. J. (2009) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048670903279887 · Cited by 217
Antidepressants for treating depression in dementia
Bains, J., Birks, J., & Dening, T. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003944 · Cited by 214
The rate of conversion of mild cognitive impairment to dementia: predictive role of depression
Gabryelewicz, T., Styczynska, M., Luczywek, E., Barczak, A., Pfeffer, A., Androsiuk, W., Chodakowska‐Zebrowska, M., Wasiak, B., Peplonska, B., & Barcikowska, M. (2007) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1716 · Cited by 199
“Early depressive symptoms among subjects with MCI and the lack of improvement in cognition scores, following the treatment of depression in MCI patients may be associated with an increased risk of meeting diagnostic criteria for dementia during the follow-up (Li et al., 2001; Devanand et al., 2003).”
BackgroundPrado, C. E., Watt, S., & Crowe, S. F. (2018) · Neuropsychology Review · doi:10.1007/s11065-018-9369-5 · Cited by 188
Antidepressants for treating depression in dementia
Dudas, R., Malouf, R., McCleery, J., & Dening, T. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003944.pub2 · Cited by 175
Pimontel, M. A., Rindskopf, D., Rutherford, B. R., Brown, P. J., Roose, S. P., & Sneed, J. R. (2016) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2015.05.010 · Cited by 110
Self-citationCognitive Effects of Pharmacotherapy for Major Depressive Disorder: A Systematic Review
Keefe, R. S. E., McClintock, S. M., Roth, R. M., Doraiswamy, P. M., Tiger, S., & Madhoo, M. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13r08609 · Cited by 107
Psychological treatments for depression and anxiety in dementia and mild cognitive impairment
Orgeta, V., Leung, P., del-Pino-Casado, R., Qazi, A., Orrell, M., Spector, A. E., & Methley, A. M. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009125.pub3 · Cited by 103
McLennan, S. N., & Mathias, J. L. (2010) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2431 · Cited by 95
Change in Cognitive Functioning Following Acute Antidepressant Treatment in Late-Life Depression
Culang, M. E., Sneed, J. R., Keilp, J. G., Rutherford, B. R., Pelton, G. H., Devanand, D. P., & Roose, S. P. (2009) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181b4bf4a · Cited by 94
Self-citationCognitive Impairment in Depressed Older Adults: Implications for Prognosis and Treatment
Morimoto, S. S., Kanellopoulos, T., & Alexopoulos, G. S. (2014) · Psychiatric Annals · doi:10.3928/00485713-20140306-05 · Cited by 66
Barch, D. M., D'Angelo, G., Pieper, C., Wilkins, C. H., Welsh-Bohmer, K., Taylor, W., Garcia, K. S., Gersing, K., Doraiswamy, P. M., & Sheline, Y. I. (2012) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e318246b6cb · Cited by 64
“Some prior research suggests that cognitive improvement over the course of treatment may vary as a function of whether an individual was considered to have remitted to treatment in terms of depression status (22, 30).”
Antidepressant Use and Cognitive Decline: The Health and Retirement Study
Saczynski, J. S., Rosen, A. B., McCammon, R. J., Zivin, K., Andrade, S. E., Langa, K. M., Vijan, S., Pirraglia, P. A., & Briesacher, B. A. (2015) · The American Journal of Medicine · doi:10.1016/j.amjmed.2015.01.007 · Cited by 56
Devanand, D. P., Pelton, G. H., D'Antonio, K., Ciarleglio, A., Scodes, J., Andrews, H., Lunsford, J., Beyer, J. L., Petrella, J. R., Sneed, J., et al. (2018) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2018.05.008 · Cited by 47
Self-citationSertraline Improves Executive Function in Patients With Vascular Cognitive Impairment
Royall, D. R., Cordes, J. A., Román, G., Velez, A., Edwards, A., Schillerstrom, J. S., & Polk, M. J. (2009) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.2009.21.4.445 · Cited by 26
Peakman, G., Karunatilake, N., Seynaeve, M., Perera, G., Aarsland, D., Stewart, R., & Mueller, C. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-035147 · Cited by 21
Metadata
- Authors
- Devanand, D. P., Pelton, G. H., Marston, K., Camacho, Y., Roose, S. P., Stern, Y., & Sackeim, H. A.
- Venue
- International Journal of Geriatric Psychiatry
- Publisher
- Wiley
- Published
- 2003-01-16
- Volume
- 18
- Issue
- 2
- Pages
- 123-130
- ISSN
- 0885-6230 (ISSN-L)
- 1099-1166
- OpenAlex
- W2078664322
- Cited by
- 132
- References
- 7
- FWCI
- 4.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.